Becton Dickinson and Company (NYSE:BDX) traded with a cut of -1.29 points or -0.77% at $166.01 per share. As per the last available information, the stock aggregated $35.07 million in upticks and $20.01 million in downticks, keeping the net money flow capped at $15.05 million. The up/down ratio was found to be 1.75. For the week, the shares have seen a change of -1.94% in the share price.A block trade of $17.48 million in upticks and $0 million in downticks also took place during the day. The up/down ratio for the block stood at 0. The net money flow for this transaction was $17.48 million.
Becton, Dickinson and Company has dropped 2.07% in the last five trading days, however, the shares have posted positive gains of 0.6% in the last 4 weeks. Becton, Dickinson and Company is up 10.78% in the last 3-month period. Year-to-Date the stock performance stands at 8.49%.
Currently the company Insiders own 1.6% of Becton Dickinson and Company shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -21.24% . Institutional Investors own 85.48% of Becton Dickinson and Company shares. During last six month period, the net percent change held by insiders has seen a change of -21.24%. . On the companys insider trading activities, The Securities and Exchange Commission has divulged that Gallagher John E, officer (VP, Corp Finance and Treasurer) of Becton Dickinson & Co, had unloaded 1,931 shares at an average price of $169.87 in a transaction dated on June 13, 2016. The total value of the transaction was worth $328,019.
Becton Dickinson and Company (NYSE:BDX) witnessed a decline in the market cap on Friday as its shares dropped 0.9% or 1.51 points. After the session commenced at $167.37, the stock reached the higher end at $167.37 while it hit a low of $164.63. With the volume soaring to 909,715 shares, the last trade was called at $165.79. The company has a 52-week high of $171.64. The company has a market cap of $35,181 million and there are 212,202,000 shares in outstanding. The 52-week low of the share price is $128.87.
Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.